TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Neurotrauma Research Sweden Nrs AB
Closing information (x1000 NOK)
| Closing information | 2025/04 | 2024/04 | 2023/04 |
| Turnover |
512
|
491
|
500 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-216
|
-134
|
-189 |
| EBITDA |
-187
|
-107
|
-160 |
| Total assets |
7,608
|
7,297
|
7,750 |
| Current assets |
133
|
116
|
363 |
| Current liabilities |
578
|
325
|
220 |
| Equity capital |
7,030
|
6,973
|
7,530 |
| - share capital |
108
|
101
|
104 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2025/04 | 2024/04 | 2023/04 |
| Solvency |
92.4%
|
95.6%
|
97.2% |
| Turnover per employee |
512
|
491
|
500 |
| Profit as a percentage of turnover |
-42.2%
|
-27.3%
|
-37.8% |
| Return on assets (ROA) |
-2.8%
|
-1.8%
|
-2.4% |
| Current ratio |
23.0%
|
35.7%
|
165.0% |
| Return on equity (ROE) |
-3.1%
|
-1.9%
|
-2.5% |
| Change turnover |
-13
|
6
|
-204 |
| Change turnover % |
-2%
|
1%
|
-29% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/04 | 2024/04 | 2023/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.